VI

VIVOZON PHARMACEUTICAL CO., LTD.

Develops innovative, non-narcotic drugs for pain and central nervous system (CNS) diseases.

082800 | KO

Overview

Corporate Details

ISIN(s):
KR7082800004
LEI:
Country:
South Korea
Address:
경기도 화성시 향남읍 제약공단2길 34-40, 화성시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Vivozon Pharmaceutical Co., Ltd. is a global drug development company established in 2008, focused on creating innovative treatments for pain and central nervous system (CNS) diseases. The company's core research centers on a multi-target drug discovery platform designed to develop chemical drugs with synergistic efficacy. Its lead pipeline candidate is Opiranserin (VVZ-149), a first-in-class, non-narcotic injectable analgesic. Vivozon utilizes an efficacy-based screening system from the early stages of discovery to advance its pipeline, which also targets conditions such as depression, substance use disorders, and neurodegenerative diseases.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-11 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.3 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.4 MB
2025-07-17 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.1 KB
2025-07-14 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-06-27 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 121.1 KB
2025-06-16 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.0 KB
2025-05-22 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등거래계획보고서
Korean 54.9 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.4 MB
2025-04-18 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 111.3 KB
2025-04-14 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.0 KB
2025-04-04 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 108.4 KB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 17.7 KB
2025-03-27 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-03-24 00:00
Transaction in Own Shares
자기주식처분결과보고서
Korean 17.7 KB
2025-03-21 00:00
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
Korean 28.8 KB

Automate Your Workflow. Get a real-time feed of all VIVOZON PHARMACEUTICAL CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for VIVOZON PHARMACEUTICAL CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for VIVOZON PHARMACEUTICAL CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Mineralys Therapeutics, Inc. Logo
Developing targeted treatments for hypertension & CKD driven by elevated aldosterone.
United States of America
MLYS
MiNK Therapeutics, Inc. Logo
Developing allogeneic iNKT cell therapies for cancer and immune-mediated diseases.
United States of America
INKT
MIRA PHARMACEUTICALS, INC. Logo
Develops novel ketamine and THC analogs for neurologic and neuropsychiatric disorders.
United States of America
MIRA
Mirum Pharmaceuticals, Inc. Logo
Develops and commercializes therapies for rare, debilitating liver diseases in children and adults.
United States of America
MIRM
Mithra Pharmaceuticals S.A. Logo
Biotech firm developing pharma for women's health: contraception, fertility, and menopause.
Belgium
MITRA
MIZUHO MEDY CO.,LTD. Logo
Develops rapid diagnostic tests & gene analyzers for clinical, research & agricultural markets.
Japan
4595
MOA Life Plus Co. Ltd. Logo
Develops immunotherapies & consumer solutions for immunity, skin rejuvenation, and pet care.
South Korea
142760
Moberg Pharma Logo
Develops & commercializes a leading topical treatment for nail fungus for European markets.
Sweden
MOB
Mochida Pharmaceutical Co.,Ltd. Logo
An R&D-driven company making drugs, skincare, and medical equipment for specialized fields.
Japan
4534
Moderna, Inc. Logo
Pioneering mRNA science to create transformative medicines and vaccines for diverse diseases.
United States of America
MRNA

Talk to a Data Expert

Have a question? We'll get back to you promptly.